Initiation of lipid-lowering therapy as primary prevention of cardiovascular disease in the elderly.
José Manuel Vinuesa-HernandoIsabel Aguilar-PalacioMaría José RabanaqueVictoria García-CárdenasMaría Jesús LallanaAdriana GambaSara MaloPublished in: British journal of clinical pharmacology (2024)
Non-initiation and early discontinuation are common among older people prescribed lipid-lowering drugs as primary prevention of cardiovascular disease for the first time. The presence of chronic pathologies other than cardiovascular ones should be considered when assessing whether or not to prescribe these drugs in the elderly.